Impact of AR-V7 protein localization in the prediction of therapeutic benefit of taxanes over androgen receptor signaling inhibitors (ARSi) in metastatic castration resistant prostate cancer (mCRPC)

被引：1
|
作者：
Scher, H. [1 ]
Graf, R. [2 ]
Schreiber, N. [1 ]
Lu, D. [2 ]
Louw, J. [2 ]
Alvarez, H. A. Vargas [1 ]
Bambury, R. [1 ]
Danila, D. [1 ]
McLaughlin, B. [1 ]
Heller, G. [3 ]
Fleisher, M. [1 ]
Dittamore, R. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Med, 1275 York Ave, New York, NY 10021 USA
[2] Epic Sci Inc, Translat Res, San Diego, CA USA
[3] Mem Sloan Kettering Canc Ctr, Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw372.12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
728PD
引用
收藏
页数：1
相关论文
共 50 条
  • [1] AR splice variant 7 (AR-V7) and response to taxanes in men with metastatic castration-resistant prostate cancer (mCRPC).
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Chen, Yan
    Luber, Brandon
    Wang, Hao
    Nakazawa, Mary
    De Marzo, Angelo M.
    Isaacs, William B.
    Nadal, Rosa
    Paller, Channing Judith
    Denmeade, Samuel R.
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    Luo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [2] Androgen receptor splice variant, AR-V7, and resistance to enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC)
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Wang, Hao
    Luber, Brandon
    Nakazawa, Mary
    Chen, Yan
    Roeser, Jeffrey C.
    Fedor, Helen L.
    Lotan, Tamara L.
    Zheng, Qizhi
    De Marzo, Angelo M.
    Isaacs, John T.
    Isaacs, William B.
    Nadal, Rosa
    Paller, Channing Judith
    Denmeade, Samuel R.
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    Luo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Study on Pradiction of AR-V7 and CTC Circulation in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
    Rexer, H.
    Hammerer, P.
    Schostak, M.
    Koenig, F.
    AKTUELLE UROLOGIE, 2018, 49 (05) : 392 - 393
  • [4] Nuclear localized AR-V7 protein as a predictive biomarker for treatment selection in metastatic castration resistant prostate cancer (mCRPC)
    Scher, Howard I.
    Lu, David
    Schreiber, Nicole A.
    Louw, Jessica
    Graf, Ryon P.
    Johnson, Ann
    Jendrisak, Adam
    Heller, Glenn
    Bambury, Richard
    Alverez, Herbert A. Vargas
    McLaughlin, Brigit
    Wahl, Justin
    Greene, Stephanie
    Fleisher, Martin
    Dittamore, Ryan
    CANCER RESEARCH, 2016, 76
  • [5] Clinical utility of androgen-receptor splice variant 7 (AR-V7) determinations in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Piana, Danilo
    Luo, Jun
    Markowski, Mark Christopher
    Shenderov, Eugene
    Antonarakis, Emmanuel S.
    Eisenberger, Mario A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Plasma androgen receptor (pAR) status and activity of taxanes in metastatic castration resistant prostate cancer (mCRPC).
    Conteduca, Vincenza
    Jayaram, Anuradha
    Romero-Laorden, Nuria
    Wetterskog, Daniel
    Salvi, Samanta
    Gurioli, Giorgia
    Scarpi, Emanuela
    Castro, Elena
    Castro, Elena
    Lolli, Cristian
    Schepisi, Giuseppe
    Wingate, Anna
    Medina, Ana
    Fornarini, Giuseppe
    Basso, Umberto
    Mellado, Begona
    Gonzalez-Billalabeitia, Enrique
    Olmos, David
    Attard, Gerhardt
    De Giorgi, Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Targeted androgen receptor (AR) protein degradation for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
    Han, Xin
    Zhao, Lijie
    Xiang, Weiguo
    Qin, Chong
    Miao, Bukeyan
    Xu, Tianfeng
    Lu, Jianfeng
    Wang, Mi
    Wang, Shaomeng
    CANCER RESEARCH, 2020, 80 (16)
  • [8] DETECTION OF ANDROGEN RECEPTOR VARIANT 7 (AR-V7) IN WHOLE BLOOD RNA OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS TREATED WITH ABIRATERONE ACETATE (ABI)
    Todenhoefer, Tilman
    Azad, Arun
    Gao, Jian
    Stewart, Craig
    Eigl, Bernie
    Stenzl, Arnulf
    Teich, Miriam
    Black, Peter
    Joshua, Anthony
    Chi, Kim
    JOURNAL OF UROLOGY, 2016, 195 (04): : E655 - E656
  • [9] DETECTION OF AR-V7 TRANSCRIPTS IN WHOLE BLOOD RNA OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Kwan, Edmond M.
    To, Sarah
    Fettke, Heidi
    Docanto, Maria
    Martelotto, Luciano
    Azad, Arun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 50 - 50
  • [10] The association of AR-V7 with resistance to Abiraterone in metastatic castration-resistant prostate cancer
    Wang, Shuo
    Cao, Yudong
    Tang, Xingxing
    Yang, Xiao
    Ma, Jinchao
    Yu, Ziyi
    Yang, Yong
    Du, Peng
    JOURNAL OF MENS HEALTH, 2022, 18 (03)
12345